Astellas Pharma US Inc.

PA 2014 Independent Pharmacies

DOJ False Claims Act

Penalty

$7.3 million

Outcome

Astellas Pharma US Inc. to Pay $7.3 Million to Resolve False<br /> Claims Act Allegations Relating to Marketing of Drug Mycamine

Details

Astellas Pharma US Inc. — DOJ Enforcement (2014)

DOJ took enforcement action against Astellas Pharma US Inc. in PA in 2014 involving false claims act violations in the Independent Pharmacies sector.

Penalty: $7.3 million

Violation types: False Claims Act
Entity type: Pharmacy
Penalty type: Settlement
Location: PA

Source: DOJ Press Release — Astellas Pharma US Inc. to Pay $7.3 Million to Resolve False
Claims Act Allegations Relating to Marketing of Drug Mycamine

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted.

Source: DOJ Press Release — Astellas Pharma US Inc. to Pay $7.3 Million to Resolve False<br /> Claims Act Allegations Relating to Marketing of Drug Mycamine

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works